Radford-Smith GL - Search Results

1

An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunity.

Eri RD, Adams RJ, Tran TV, Tong H, Das I, Roche DK, Oancea I, Png CW, Jeffery PL, Radford-Smith GL, Cook MC, Florin TH, McGuckin MA. Eri RD, et al. Mucosal Immunol. 2011 May;4(3):354-64. doi: 10.1038/mi.2010.74. Epub 2010 Nov 24. Mucosal Immunol. 2011. PMID: 21107311 Free PMC article.

2

Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics.

Edwards JT, Radford-Smith GL, Florin TH. Edwards JT, et al. J Gastroenterol Hepatol. 2001 Nov;16(11):1235-8. doi: 10.1046/j.1440-1746.2001.02468.x. J Gastroenterol Hepatol. 2001. PMID: 11903741

3

Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases.

Florin TH, Pandeya N, Radford-Smith GL. Florin TH, et al. Gut. 2004 Jul;53(7):973-9. doi: 10.1136/gut.2003.036483. Gut. 2004. PMID: 15194646 Free PMC article.

4

CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis.

Eri R, Jonsson JR, Pandeya N, Purdie DM, Clouston AD, Martin N, Duffy D, Powell EE, Fawcett J, Florin TH, Radford-Smith GL. Eri R, et al. Genes Immun. 2004 Sep;5(6):444-50. doi: 10.1038/sj.gene.6364113. Genes Immun. 2004. PMID: 15215889

5

Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-alpha, in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy? The Infliximab User Group.

Mortimore M, Gibson PR, Selby WS, Radford-Smith GL, Florin TH; Schering Plough (Australia). Mortimore M, et al. Intern Med J. 2001 Apr;31(3):146-50. doi: 10.1046/j.1445-5994.2001.00039.x. Intern Med J. 2001. PMID: 11478343

6

Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.

Michael-Robinson JM, Pandeya N, Walsh MD, Biemer-Huttmann AE, Eri RD, Buttenshaw RL, Lincoln D, Clouston AD, Jass JR, Radford-Smith GL. Michael-Robinson JM, et al. J Pathol. 2006 Feb;208(3):381-7. doi: 10.1002/path.1895. J Pathol. 2006. PMID: 16315333

7

Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease.

Radford-Smith GL, Edwards JE, Purdie DM, Pandeya N, Watson M, Martin NG, Green A, Newman B, Florin TH. Radford-Smith GL, et al. Gut. 2002 Dec;51(6):808-13. doi: 10.1136/gut.51.6.808. Gut. 2002. PMID: 12427781 Free PMC article.

8

Angiotensinogen and transforming growth factor beta1: novel genes in the pathogenesis of Crohn's disease.

Hume GE, Fowler EV, Lincoln D, Eri R, Templeton D, Florin TH, Cavanaugh JA, Radford-Smith GL. Hume GE, et al. J Med Genet. 2006 Oct;43(10):e51. doi: 10.1136/jmg.2005.040477. J Med Genet. 2006. PMID: 17047091 Free PMC article.

9

Mycophenolate mofetil in IBD patients.

Radford-Smith GL, Taylor P, Florin TH. Radford-Smith GL, et al. Lancet. 1999 Oct 16;354(9187):1386-7. doi: 10.1016/S0140-6736(05)76240-1. Lancet. 1999. PMID: 10533889 No abstract available.

10

Treatment of steroid refractory inflammatory bowel disease (IBD) with mycophenolate mofetil (MMF).

Florin TH, Roberts RK, Watson MR, Radford-Smith GL. Florin TH, et al. Aust N Z J Med. 1998 Jun;28(3):344-5. doi: 10.1111/j.1445-5994.1998.tb01960.x. Aust N Z J Med. 1998. PMID: 9673748 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters